Physician profile
Kent E Rogers
NPI 1740255587
$667.63
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $365 · 2022: $25.91.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $214.61 | 2019-2020 | |
| Novo Nordisk INC | $87.40 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $85.43 | 2019-2020 | |
| Amarin Pharma, INC. | $74.77 | 2020 | |
| Novartis Pharmaceuticals Corporation | $37.55 | 2019 | |
| Pfizer INC. | $35.87 | 2019-2020 | |
| Amgen INC. | $30.03 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.76 | 2020 | |
| Pharmacyclics LLC, An Abbvie Company | $25.91 | 2022 | |
| Radius Health, INC. | $16.39 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $16.27 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.64 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kent Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.